Anyone involved in the transfusion chain is required to submit reports. Art. 59 TPA specifies the manufacturers or distributors of blood and blood products (blood transfusion services) and all professionals who use labile blood products or are entitled to do so, including doctors, nurses and laboratory professionals.
Reports are usually submitted to the RPHv. The various parties involved exchange information to gain as full a picture as possible of the case and pass on their findings to the RPHv. Once the clinical and diagnostic investigations have been completed, the RPHv sends the report to Swissmedic and the blood transfusion service.
The treating doctor in a practice that occasionally uses blood and labile blood products reports the adverse event directly to Swissmedic.